{"title":"The 24p3 receptor is implicated in cadmium-induced distal tubule nephrotoxicity","authors":"Ana Karen Pantaleón-Gómez , Sabino Hazael Avila-Rojas , Itzel Pamela Zavala-Guevara , Iliana Angélica Tostado-Fernández , Fanis Missirlis , Omar Emiliano Aparicio-Trejo , Belén Cuevas-López , Juan Carlos León-Contreras , Rogelio Hernández-Pando , Olivier Christophe Barbier","doi":"10.1016/j.etap.2025.104759","DOIUrl":null,"url":null,"abstract":"<div><div>Accumulation of toxic metal cadmium (Cd) in the kidney is traditionally associated with proximal tubule (PT) toxicity, but the potential involvement of the distal tubule (DT) remains less explored. A previous study suggested a role of the 24p3 receptor (24p3R), expressed in the DT, in mediating cadmium-induced damage, particularly when PT function was compromised. A murine model (C57BL/6 J male mice) employing gentamicin (GM) to impair PT reabsorption was used to redirect cadmium–metallothionein (CdMT) complexes toward the distal segment. Here, we used the same model, confirming that DT-specific injury was evident following CdMT administration, including epithelial cell flattening, vacuolization, enhanced catalase activity, lipid peroxidation, and apoptotic cell death. Cd exposure increased 24p3R expression in the DT, supporting its involvement in metal uptake. Coadministration of 24p3, an endogenous ligand of 24p3R, with CdMT significantly reduced tissue Cd levels by 75 % and alleviated histological and biochemical markers of injury, suggesting that 24p3 competes with CdMT for receptor binding, limiting Cd entry and its downstream toxicity. Administration of 24p3 alone did not provoke structural or molecular alterations in renal tissue. The results identify 24p3R as a relevant pathway in DT-targeted cadmium nephrotoxicity and highlight the potential of 24p3-based strategies for mitigating renal injury due to exposure to potentially toxic elements.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"118 ","pages":"Article 104759"},"PeriodicalIF":4.2000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668925001346","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Accumulation of toxic metal cadmium (Cd) in the kidney is traditionally associated with proximal tubule (PT) toxicity, but the potential involvement of the distal tubule (DT) remains less explored. A previous study suggested a role of the 24p3 receptor (24p3R), expressed in the DT, in mediating cadmium-induced damage, particularly when PT function was compromised. A murine model (C57BL/6 J male mice) employing gentamicin (GM) to impair PT reabsorption was used to redirect cadmium–metallothionein (CdMT) complexes toward the distal segment. Here, we used the same model, confirming that DT-specific injury was evident following CdMT administration, including epithelial cell flattening, vacuolization, enhanced catalase activity, lipid peroxidation, and apoptotic cell death. Cd exposure increased 24p3R expression in the DT, supporting its involvement in metal uptake. Coadministration of 24p3, an endogenous ligand of 24p3R, with CdMT significantly reduced tissue Cd levels by 75 % and alleviated histological and biochemical markers of injury, suggesting that 24p3 competes with CdMT for receptor binding, limiting Cd entry and its downstream toxicity. Administration of 24p3 alone did not provoke structural or molecular alterations in renal tissue. The results identify 24p3R as a relevant pathway in DT-targeted cadmium nephrotoxicity and highlight the potential of 24p3-based strategies for mitigating renal injury due to exposure to potentially toxic elements.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.